NASDAQ · STOCK
Thermo Fisher Scientific
$574.39
52W $435.27 – $643.99
53/100
$213.42B
30.8
0.87
Is TMO Bullish or Bearish?
Mixed.
Innellis AI committee rates Thermo Fisher Scientific (TMO) Watch with a composite score of 53/100
, based on 7 analysts with 43% agreement.
Last updated July 31, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +7.39 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -12.61 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Growth Analyst sees a compelling case — 5 consecutive earnings beats -- consistent execution. Value Analyst remains cautious — p/e of 30.5 is moderate-to-rich. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- P/E of 30.5 is moderate-to-rich — Value
- Price-to-book of 4.1x prices in significant intangible value — Value
- RSI at 73 is in overbought territory — Technical
- Weekly RSI at 76 -- overbought on the larger timeframe too — Technical
- Bollinger bandwidth of 16.8% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of July 31, 2026
Overall Committee Score
53/100
Agreement
43%
Analysts
7
Conviction
Contested
Sector Rank
Top 68%
of 93 Healthcare peers
Value Analyst
bearish
35
/ 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− P/E of 30.5 is moderate-to-rich
Growth Analyst
bullish
68
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 5 consecutive earnings beats -- consistent execution
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− RSI at 73 is in overbought territory
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 16.8% signals elevated volatility
Macro Analyst
neutral
58
/ 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
66
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.27 across 67 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Investment Thesis Evolution
Committee score moved marginally from 53.7 to 52.6.
- Committee agreement fell notably from 57% to 43%.
- New bearish signals: 4 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 2 appeared.
- Bearish pressure eased: 4 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst.
Analyst-level changes:
- Macro Analyst: stance bullish->neutral; score 65->58 (-8); +1 bullish signal(s).
- News Analyst: +1 bullish signal(s).
- Portfolio Manager: +2 bearish signal(s).
- Risk Analyst: +1 bearish signal(s).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-07-30 to 2026-07-31 (1 day apart).
Technical Analysis
RSI (14)
70.4
Overbought
MACD Histogram
2.554
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Mixed
Support
$554.60
Resistance
$602.10
Bollinger %B
0.84
Inside Bands
Price vs Moving Averages
EMA 9
$563.53
Above
EMA 21
$543.89
Above
EMA 50
$519.04
Above
EMA 200
$511.89
Above
Fundamental Analysis
Valuation
32
Growth
73
Profitability
0
Financial Health
74
Cash Flow
37
Valuation
P/E Ratio
30.8×
P/B Ratio
4.04×
PEG Ratio
4.14
Dividend Yield
0.00%
52W High
$643.99
52W Low
$435.27
Quality & Growth
ROE
12.6%
ROA
6.1%
Gross Margin
40.4%
Operating Margin
17.7%
Revenue Growth YoY
—
Debt / Equity
0.81
AI Fundamental Assessment
P/E ratio of 30.8 (rich relative to a 15-40x range); Price-to-book of 4.0x; PEG ratio of 4.1 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.1%; Return on assets of 0.1%; Net margin of 0.2%; Gross margin of 0.4%; Current ratio of 1.55 (healthy short-term liquidity); Debt-to-equity of 0.81; Free cash flow margin of 0.8% (thin cash generation); Free cash flow per share is positive (19.73); Most recent quarter beat estimates by 4.5%; 5 consecutive earnings beats; EPS growth accelerating (-17.2% -> +10.8% QoQ); Average YoY EPS growth of 12.5%; Analyst estimates falling over recent quarters
Get the Full TMO Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →